ro glp 1 Offers Eli Lilly's Foundayo™, the Newest GLP-1 Innovation Ro's Weight-Loss Program Review: GLP-1
Description
This study, which included around 6,400 patients, employed Cox regression analysis and confirmed that diabetic patients using GLP-1R agonistssuch as exenatide, liraglutide, dulaglutide, and semaglutide were less likely to receive a new glaucoma diagnosis (76)
2024;119:S2964
We are not prescribing it
For GLP-1s specifically, because they tend to have such an outsize impact on prescription spending, its a good idea to have a pharmacist assist in evaluating them
